|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 491/056 | |
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2392576 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09793788.2 |
| Europos patento paraiškos padavimo data | 2009-07-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-12-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-02-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2009/000773 |
| Data | 2009-07-07 |
| (87) | Numeris | WO 2010/003313 |
| Data | 2010-01-14 |
| (30) | Numeris | Data | Šalis |
| 200810132631 | 2008-07-08 | CN | |
| 200810132458 | 2008-07-17 | CN | |
| 200810188272 | 2008-12-23 | CN |
| (72) |
WANG, Yinxiang, CN
DING, Lieming, CN
TAN, Fenlai, CN
HU, Yunyan, CN
HE, Wei, CN
HAN, Bin, CN
LONG, Wei, CN
LIU, Yong, CN
AL, Haima, CN
ZHANG, Don, US
DAVIS, Charles, US
XIE, Guojian, US
|
| (73) |
Beta Pharma, Inc.,
5 Vaughn Drive, Suite 106, Princeton, NJ 08540,
US
|
| (54) | ICOTINIB HYDROCHLORIDE, SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF |
| ICOTINIB HYDROCHLORIDE, SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF |